Neil Josephson, Chief Medical Officer at Zymeworks Inc. (ZYME), sold 2,475 shares at $8.10 ($20K) on 2022-11-10, disclosed to the SEC on 2022-12-23.
Scheduled sale ($20k) by Chief Medical Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.